As an experimental AIDS vaccine approach designed to uncouple immune activation from ongoing virus replication and turnover of CD4+ lymphocytes, we and others have developed genetic systems for producing strains of SIV that are limited to a single cycle of infection [25]–[27]. Here, CD4 is linked to AIDS.